Business
FDA agrees to six-month Phase 2b Alzheimers Disease Trial
FDA agrees to six-month Phase 2b Alzheimers Disease Trial
About this update from Actinogen Medical Limited
[{"type":"text","content":"Actinogen Medical Ltd has released a press release. View Attachment","length":244,"tagName":"div"}]